​

Funding Round

Series B - Vanqua Bio

Series B - Vanqua Bio

Investment Firm

Overview

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Announced Date

Sep 14, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Omega Funds

Omega Funds

Omega Funds is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed firm.

Participant Investors

7

Investor Name
Participant InvestorOrbiMed
Participant InvestorPontifax
Participant InvestorEli Lilly
Participant InvestorOmega Funds
Participant InvestorOUP (Osage University Partners)

Round Details and Background

Vanqua Bio raised $85000000 on 2021-09-14 in Series B

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 14, 2021
Series B - Vanqua Bio
9-85.0M
Dec 01, 2020
Grant - Vanqua Bio
1-undefined
Jul 05, 2024
Venture Round - Vanqua Bio
-45.0M

Recent Activity

There is no recent news or activity for this profile.